Effect of reduced cholinergic transmission by rocuronium on the hypoxic ventilatory response in patients with obstructive sleep apnea - before and after three months of continous positive airway pressure treatment. A non-radomised, non-blinded study.

Trial Profile

Effect of reduced cholinergic transmission by rocuronium on the hypoxic ventilatory response in patients with obstructive sleep apnea - before and after three months of continous positive airway pressure treatment. A non-radomised, non-blinded study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2012

At a glance

  • Drugs Rocuronium bromide (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top